Literature DB >> 19339777

Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients.

Barbara Vicini Chilovi1, Marta Conti, Marina Zanetti, Ilenia Mazzù, Luca Rozzini, Alessandro Padovani.   

Abstract

BACKGROUND AND AIMS: Neuropsychiatric symptoms may accompany mild cognitive impairment (MCI) and assist in identifying incipient dementia. The aim of this study was to evaluate the role of apathy and depression in the conversion to dementia among MCI subjects.
METHODS: 124 MCI outpatients were investigated. Diagnosis of apathy and depression was based on clinical criteria. The main endpoint was the development of dementia within 2 years from the enrolment.
RESULTS: 50 (40.3%) subjects were classified as MCI normal, 38 (30.7%) as MCI depressed, 21 (16.9%) as MCI depressed-apathetic and 15 (12.1%) as apathetic. The rates of conversion were 24% for MCI normal, 7.9% for MCI depressed, 19% for MCI depressed-apathetic and 60% for MCI apathetic. Diagnosis of apathy was a risk factor for conversion apart from age, functional and cognitive status at baseline (OR = 7.07; 95% CI 1.9-25.1; p = 0.003). In contrast, MCI depressed subjects had a reduced risk of conversion (OR = 0.10; 95% CI 0.02-0.4; p = 0.001).
CONCLUSION: These findings argue for a differential role of apathy and depression in the development of dementia, and suggest the need of dissecting in MCI patients apathy and depression symptoms in the reading of mood disorders.

Entities:  

Mesh:

Year:  2009        PMID: 19339777     DOI: 10.1159/000210045

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  32 in total

Review 1.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

Review 2.  Apathy in neuropsychiatric disease: diagnosis, pathophysiology, and treatment.

Authors:  Thomas N Chase
Journal:  Neurotox Res       Date:  2010-05-15       Impact factor: 3.911

3.  State of the Science: Apathy As a Model for Investigating Behavioral and Psychological Symptoms in Dementia.

Authors:  Lauren Massimo; Helen C Kales; Ann Kolanowski
Journal:  J Am Geriatr Soc       Date:  2018-04       Impact factor: 5.562

Review 4.  The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link?

Authors:  Adriana P Hermida; William M McDonald; Kyle Steenland; Allan Levey
Journal:  Expert Rev Neurother       Date:  2012-11       Impact factor: 4.618

Review 5.  Neuropsychiatric Symptoms in Mild Cognitive Impairment.

Authors:  Damien Gallagher; Corinne E Fischer; Andrea Iaboni
Journal:  Can J Psychiatry       Date:  2017-03       Impact factor: 4.356

6.  Neural correlates of apathy in late-life depression: a pilot [18 F]FDDNP positron emission tomography study.

Authors:  Harris A Eyre; Prabha Siddarth; Kathleen van Dyk; Natalie St Cyr; Bernhard T Baune; Jorge R Barrio; Gary W Small; Helen Lavretsky
Journal:  Psychogeriatrics       Date:  2017-01-28       Impact factor: 2.440

7.  Association of Apathy With Risk of Incident Dementia: A Systematic Review and Meta-analysis.

Authors:  Jan Willem van Dalen; Lennard L van Wanrooij; Eric P Moll van Charante; Carol Brayne; Willem A van Gool; Edo Richard
Journal:  JAMA Psychiatry       Date:  2018-10-01       Impact factor: 21.596

Review 8.  Depression associated with dementia.

Authors:  H Gutzmann; A Qazi
Journal:  Z Gerontol Geriatr       Date:  2015-05-12       Impact factor: 1.281

9.  Are guidelines needed for the diagnosis and management of incipient Alzheimer's disease and mild cognitive impairment?

Authors:  Katie Palmer; Massimo Musicco; Carlo Caltagirone
Journal:  Int J Alzheimers Dis       Date:  2010-08-17

10.  Affective Neuropsychiatric Symptoms as Early Signs of Dementia Risk in Older Adults.

Authors:  Jung Yun Jang; Jean K Ho; Anna E Blanken; Shubir Dutt; Daniel A Nation
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.